Irvine Clinical Research: Comprehensive Company Profile

Background

Irvine Clinical Research (ICR), established in 1978, is an independent, physician investigator-owned medical research clinic located in Irvine, California. The organization specializes in conducting Phase II-IV clinical trials, focusing primarily on neurology and psychiatry. ICR is dedicated to advancing medical knowledge by researching investigational medicines and providing no-cost, study-related care to participants.

Key Strategic Focus

ICR's strategic objectives include:

Specialization in CNS Therapeutics: The clinic has a significant emphasis on central nervous system (CNS) disorders, particularly Alzheimer's Disease and Major Depressive Disorder.

Rapid Enrollment and Quality Data: ICR is recognized for its ability to enroll subjects quickly and produce high-quality data for sponsors.

Diverse Patient Demographics: Leveraging its location in the diverse Los Angeles area, ICR recruits participants from various ethnic backgrounds, enhancing the generalizability of its research findings.

Financials and Funding

As of May 2025, ICR reported annual revenues of approximately $3.8 million. The clinic has raised a total of $150,000 in funding over one round. These financial resources are allocated towards expanding research capabilities, enhancing facilities, and supporting ongoing clinical trials.

Pipeline Development

ICR has been involved in over 300 clinical research trials, with a particular focus on early Alzheimer's Disease and Major Depressive Disorder. The clinic collaborates with leading pharmaceutical companies to conduct multiple phases of clinical research studies, contributing to the development of new treatments in these areas.

Technological Platform and Innovation

ICR distinguishes itself through:

Advanced Facilities: The clinic features multiple exam rooms, a CLIA-waived laboratory, certified phlebotomists, and specialized equipment such as -20° and -70° freezers, ensuring the integrity of biological samples.

Comprehensive Services: ICR offers a range of services, including EKG/ECG, uroflow, bladder ultrasound, and access to radiology scans (X-Ray, MRI, CT, PET) through affiliate partners.

Leadership Team

ICR's leadership comprises experienced professionals:

Dr. Elly Lee, MD: Chief Medical Officer & President, with over 20 years of research experience in neurology and psychiatry.

Dr. Edward Zamrini, MD: Director of Neurology, an internationally recognized memory disorders specialist with extensive experience in Alzheimer's Disease clinical trials.

Ralph Lee, ACRP-CP: Site Director & CEO, with over 15 years of experience in research business operations.

Competitor Profile

Market Insights and Dynamics

The clinical research industry is experiencing growth, driven by increasing demand for new treatments and therapies. ICR's focus on CNS disorders positions it within a competitive niche, addressing prevalent conditions such as Alzheimer's Disease and depression.

Competitor Analysis

Key competitors include:

Collaborative Neuroscience Research (CNS): Operates outpatient clinics and provides clinical research services in neurology and psychiatry.

MediSpect Medical Research: A clinical research center offering services in various therapeutic areas.

Banner Life Sciences: An innovative specialty pharmaceutical company involved in clinical research.

Strategic Collaborations and Partnerships

ICR collaborates with leading pharmaceutical companies to conduct clinical trials, contributing to the development of new treatments in neurology and psychiatry. The clinic's location within the Alzheimer's Orange County building facilitates community engagement and access to a broad patient population.

Operational Insights

ICR's strategic location in Irvine, California, provides access to a diverse patient population, enhancing the generalizability of research findings. The clinic's commitment to rapid enrollment and high-quality data production strengthens its competitive position in the clinical research industry.

Strategic Opportunities and Future Directions

ICR aims to expand its research capabilities by increasing the number of clinical trials and diversifying into additional therapeutic areas. The clinic plans to leverage technological advancements to enhance data collection and analysis, further improving the quality and efficiency of its research.